230 related articles for article (PubMed ID: 32258128)
1. Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma.
Mei J; Wang H; Wang R; Pan J; Liu C; Xu J
Biomed Res Int; 2020; 2020():5751939. PubMed ID: 32258128
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer.
Fan Y; Gao Z; Li X; Wei S; Yuan K
Bioengineered; 2021 Dec; 12(1):6210-6228. PubMed ID: 34486486
[TBL] [Abstract][Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
4. Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.
Chen L; Huang Y; Zhou L; Lian Y; Wang J; Chen D; Wei H; Huang M; Huang Y
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31371628
[No Abstract] [Full Text] [Related]
5. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
6. Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma.
Liu Y; Xu Y; Jiang M; Chen W; Zhu X
J Cancer; 2021; 12(20):6254-6264. PubMed ID: 34539898
[No Abstract] [Full Text] [Related]
7. Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma.
Mei J; Yang X; Xia D; Zhou W; Gu D; Wang H; Liu C
Mol Genet Genomic Med; 2020 Sep; 8(9):e1384. PubMed ID: 32588988
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
[TBL] [Abstract][Full Text] [Related]
9. Identification of CDC25C as a Potential Biomarker in Hepatocellular Carcinoma Using Bioinformatics Analysis.
Xun R; Lu H; Wang X
Technol Cancer Res Treat; 2020; 19():1533033820967474. PubMed ID: 33111630
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
Wang J; Peng R; Zhang Z; Zhang Y; Dai Y; Sun Y
Biomed Res Int; 2021; 2021():6662114. PubMed ID: 33688500
[TBL] [Abstract][Full Text] [Related]
12. Prognostic potential of PRPF3 in hepatocellular carcinoma.
Liu Y; Yang Y; Luo Y; Wang J; Lu X; Yang Z; Yang J
Aging (Albany NY); 2020 Jan; 12(1):912-930. PubMed ID: 31926109
[TBL] [Abstract][Full Text] [Related]
13. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
Liu R; Wang G; Zhang C; Bai D
World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
[TBL] [Abstract][Full Text] [Related]
14. Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Tan W; Peng S; Li Z; Zhang R; Xiao Y; Chen X; Zhu J; Li B; Lv X
Comput Math Methods Med; 2022; 2022():2021613. PubMed ID: 35069777
[TBL] [Abstract][Full Text] [Related]
15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus‑associated hepatocellular carcinoma.
Wang X; Huang K; Zeng X; Liu Z; Liao X; Yang C; Yu T; Han C; Zhu G; Qin W; Peng T
Oncol Rep; 2019 May; 41(5):2855-2875. PubMed ID: 30896816
[TBL] [Abstract][Full Text] [Related]
17. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma.
Yu DC; Chen XY; Li X; Zhou HY; Yu DQ; Yu XL; Hu YC; Zhang RH; Zhang XB; Zhang K; An JD
Sci Rep; 2021 May; 11(1):11165. PubMed ID: 34045512
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma.
Wang H; Xu F; Yang F; Lv L; Jiang Y
Sci Rep; 2021 Jul; 11(1):14611. PubMed ID: 34272452
[TBL] [Abstract][Full Text] [Related]
20. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
